Self-pay GLP-1 Options Challenge How Employers Define Drug Benefits

As employers reconsider GLP-1 coverage, direct-to-patient self-pay options starting at $149/month are forcing plan sponsors to re-evaluate what pharmacy benefits are actually delivering.

SHARx CGO Paul Pruitt asks, “If employees can increasingly obtain GLP-1 medications outside the health plan, what does that say about the value that the employers’ pharmacy benefits actually provide?”